Nonenzymatic glycation of high-density lipoprotein impairs its anti-inflammatory effects in innate immunity

Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1

(2011) Donghui Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Inflammation, high-density lipoprotein and cardiovascular dysfunction

(2011) Michael J Haas et al.   CURRENT OPINION IN INFECTIOUS DISEASES

The role of HDL in innate immunity

(2010) Kenneth R. Feingold et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats

(2009) Zhenghao Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation

(2009) Stefan Barlage et al.   INTENSIVE CARE MEDICINE

High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response

(2008) Andrew J. Murphy et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HDL Remodeling During the Acute Phase Response

(2008) Anisa Jahangiri et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Why is HDL functionally deficient in type 2 diabetes?

(2008) Anatol Kontush et al.   Current Diabetes Reports

Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mice

(2008) Yunlong Wang et al.   JOURNAL OF LIPID RESEARCH